Pine Trail Capital Trust Provides Update on Qualifying

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
70
Pine Trail Capital Trust Provides Update on Qualifying Transaction

NOT FOR DISTRIBUTION IN THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

CALGARY, Alberta, Aug. 22, 2018 (GLOBE NEWSWIRE) -- PINE TRAIL CAPITAL TRUST ("Pine Trail" or the "Trust") (TSXV: PINE.P), a capital pool company, is pleased to announce that it is diligently proceeding with the previously announced acquisition (the “Acquisition”) of a medical office building located in Picton, Ontario (the “Property”).  As disclosed on May 16, 2018, the Acquisition shall constitute the Qualifying Transaction (as such term is defined by the policies of the TSXV) of the Trust. The vendor of the Property and the Trust have entered into an amending agreement to push the anticipated target closing date to September 21, 2018. In consideration for this amendment, the Trust has agreed to pay a third $25,000 deposit towards the purchase price of the Property.

Following completion of the Acquisition, in accordance with Pine Trail's declaration of trust, Pine Trail will become an open-ended real estate investment trust. Subject to the approval of the TSXV, the resulting issuer is expected to list as a Tier 2 Real Estate Issuer and will change its name to Pine Trail Real Estate Investment Trust.

Additional information about the Property as well as the material terms of the acquisition will be set out in the final filing statement (the "Filing Statement") to be filed with the TSXV and on SEDAR.

Additional Information About the Property

The Property is a medical office building located at 389 Main Street, Picton, Ontario, Canada in close proximity to Kingston, Ontario. The Property is situated on approximately 2.5 acres of land and contains approximately 12,000 square feet of leasable space. As of the date of this press release, the Property is primarily occupied by medical tenants and produces average annual rent in the amount of $16 per square foot and has a net operating income of approximately $240,000 per annum. The Property is 100% leased, and its tenants have a weighted average lease term of approximately 3 years.

Sponsorship

Sponsorship of a Qualifying Transaction is required by the TSXV unless exempt in accordance with TSXV policies. The Trust has applied for a waiver from the TSXV of the sponsorship requirement, but if such waiver is not obtained, the Trust will then retain a qualified sponsor.

FOR FURTHER INFORMATION PLEASE CONTACT

David Luu, CFO and Corporate Secretary
Phone: (416) 583-5513

This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "does not expect", "is expected", "estimates", "intends", "anticipates", "does not anticipate", "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Trust to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include statements concerning the terms and completion of the Acquisition, the timing of and the Acquisition and sponsorship of the Trust and waiver from such requirement. Accordingly, readers should not place undue reliance on forward-looking statements. The factors identified above are not intended to represent a complete list of the factors that could affect the Trust. The forward-looking statements contained in this press release are made as of the date of this press release, and Pine Trail does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by securities law. 

Completion of the proposed transaction is subject to a number of conditions, including but not limited to, TSXV acceptance and if applicable pursuant to TSXV requirements, majority of the minority shareholder approval. Where applicable, the transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the Filing Statement to be prepared in connection with the transaction, any information released or received with respect to such transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

The TSXV has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 228

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 73

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 21

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 124

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 119

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Ericsson Buybacks: Strategic Moves or Market Maneuver?

Updated Category News Views 10

Breaking Down Ericsson's Strategic Share Buybacks When a company like Ericsson starts pulling stocks off the shelves like they're on sale, it's time to take notice. Between November 2nd and 6th, Ericsson, that telecom giant we all know, went on a little shopping spree, snapping up 500,000 of its own Class B shares. Why should we care? Well, it's a part of their hefty SEK...

Continue Reading
Inside Kristallnacht: An XR Journey for a New World

Updated Category News Views 67

Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

TC BioPharm's Continued Trading Highlights Market Confidence

Updated Category News Views 156

TC BioPharm Continues to Trade On Nasdaq TC BioPharm (Holdings) PLC, recognized by the ticker symbol TCBP, is actively trading on the Nasdaq Global Select Market. This clinical-stage biotechnology company is notably focused on developing allogeneic gamma-delta T cell therapies, primarily targeting cancer and various other medical conditions. Sustained Trading Activity The...

Continue Reading
Innovative AI Partnership Enhances Retail Security Solutions

Updated Category News Views 65

RaptorVision and Veesion Unite for Retail Excellence In a significant development for the retail industry, RaptorVision and Veesion have announced a global strategic partnership. This collaboration merges Veesion’s advanced concealment detection behavioral analytics with RaptorVision’s AI Event-Based Product Engagement and Integration Platform tailored for the retail...

Continue Reading
ADM's Q2 2025 Financial Performance: Insights and Trends

Updated Category News Views 152

ADM's Financial Overview for Q2 2025 ADM Aéroports de Montréal has released its financial results for the second quarter of 2025. This comprehensive report encompasses passenger traffic data, revenue figures, and insights into ongoing capital investment projects at YUL Montréal-Trudeau International Airport. Key Highlights of the Q2 Results The second quarter of 2025...

Continue Reading
Octopus AIM VCT Welcomes New Non-Executive Director

Updated Category News Views 184

Octopus AIM VCT Announces a Strategic Appointment Octopus AIM VCT plc is thrilled to share the exciting news of David Docherty joining the team as an independent Non-Executive Director. His official start will follow the upcoming Annual General Meeting. This strategic move reflects the company's commitment to enhance its governance and leadership. A Wealth of Experience...

Continue Reading
Enhancing Cybersecurity: New Designation for Risk Management Pros

Updated Category News Views 177

Introducing the Associate in Cyber Risk Management Designation In today's digital age, cyber risks have become one of the most pressing challenges for organizations globally. An alarming number of C-level executives—87% according to a recent survey—acknowledge that their companies are not fully prepared to face potential cyberattacks. Recognizing this critical issue,...

Continue Reading